TransCode Therapeutics, Inc. - Common Stock (NQ:RNAZ)
8.160
+0.510
(+6.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2025
Add to My Watchlist
All News about TransCode Therapeutics, Inc. - Common Stock


12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
Via Benzinga

TransCode Therapeutics Withdraws Public Offering
October 30, 2023
Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session
October 27, 2023
Via Benzinga


Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings
October 27, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities


12 Health Care Stocks Moving In Friday's Pre-Market Session
October 27, 2023
Via Benzinga







12 Health Care Stocks Moving In Thursday's After-Market Session
October 26, 2023
Via Benzinga

TransCode Therapeutics Announces Public Offering of Common Stock
October 26, 2023
Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 26, 2023
Via Benzinga




12 Health Care Stocks Moving In Tuesday's Intraday Session
October 24, 2023
Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 24, 2023
Via Benzinga


12 Health Care Stocks Moving In Monday's Pre-Market Session
October 16, 2023
Via Benzinga


TransCode Therapeutics Announces Closing of $8.5 Million Public Offering
September 28, 2023
Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday
October 02, 2023
Via Benzinga



Nasdaq Down 1.5%; Immunovant Shares Spike Higher
September 26, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free